A new subunit vaccine based on nucleoprotein nanoparticles confers partial clinical and virological protection in calves against bovine respiratory syncytial virus

Vaccine

Volumn 28, Issue 21, 2010, Pages 3722-3734

  Riffault, Sabine ^a   Meyer, Gilles ^b   Deplanche, Martine ^b   Dubuquoy, Catherine ^a   Durand, Guillaume ^a   Soulestin, Marion ^b   Castagné, Nathalie ^a   Bernard, Julie ^a   Bernardet, Philippe ^c   Dubosclard, Virginie ^a   Bernex, Florence ^d   Petit Camurdan, Agnès ^a   Deville, Sébastien ^e   Schwartz Cornil, Isabelle ^a   Eléouët, Jean François ^a  

^a INRA Institut National de la Recherche Agronomique   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c CEMAGREF   (France)

^d ECOLE NATIONALE VÉTÉRINAIRE D ALFORT   (France)

^e SEPPIC   (France)

Author keywords

Bronchopneumonia; Calves; Nucleoprotein; Respiratory syncytial virus

Indexed keywords

IMMUNOLOGICAL ADJUVANT; MONTANIDE ISA 51; NANOPARTICLE; NUCLEOPROTEIN; SUBUNIT VACCINE; VIRUS ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BOVINE RESPIRATORY SYNCYTIAL VIRUS INFECTION; BRONCHOPNEUMONIA; CALF (BOVINE); CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS PROTECTION; IMMUNE RESPONSE; IMMUNIZATION; LYMPH NODE; MALE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIRUS LOAD;

ADJUVANTS, IMMUNOLOGIC; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, VIRAL; ANTIBODY FORMATION; CATTLE; CATTLE DISEASES; CROSS PROTECTION; IMMUNITY, CELLULAR; LUNG; MALE; MOLECULAR SEQUENCE DATA; NANOPARTICLES; NUCLEOPROTEINS; RECOMBINANT PROTEINS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS VACCINES; RESPIRATORY SYNCYTIAL VIRUS, BOVINE; VACCINES, SUBUNIT; VIRAL LOAD; VIRAL PROTEINS;

EID: 77953137011     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.03.008     Document Type: Article

References (48)

1. Meyer G., Deplanche M., and Schelcher F. Human and bovine respiratory syncytial virus vaccine research and development. Comp Immunol Microbiol Infect Dis 31 2-3 (2008) 191-225
2. Valarcher J.F., and Taylor G. Bovine respiratory syncytial virus infection. Vet Res 38 2 (2007) 153-180
3. Elvander M. Severe respiratory disease in dairy cows caused by infection with bovine respiratory syncytial virus. Vet Rec 138 5 (1996) 101-105
4. Openshaw P.J., Yamaguchi Y., and Tregoning J.S. Childhood infections, the developing immune system, and the origins of asthma. J Allergy Clin Immunol 114 6 (2004) 1275-1277
5. Kapikian A.Z., Mitchell R.H., Chanock R.M., Shvedoff R.A., and Stewart C.E. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am J Epidemiol 89 4 (1969) 405-421
6. Antonis A.F., Schrijver R.S., Daus F., Steverink P.J., Stockhofe N., Hensen E.J., et al. Vaccine-induced immunopathology during bovine respiratory syncytial virus infection: exploring the parameters of pathogenesis. J Virol 77 22 (2003) 12067-12073
7. Kimman T.G., Sol J., Westenbrink F., and Straver P.J. A severe outbreak of respiratory tract disease associated with bovine respiratory syncytial virus probably enhanced by vaccination with modified live vaccine. Vet Q 11 4 (1989) 250-253
8. Openshaw P.J., and Tregoning J.S. Immune responses and disease enhancement during respiratory syncytial virus infection. Clin Microbiol Rev 18 3 (2005) 541-555
9. Delgado M.F., Coviello S., Monsalvo A.C., Melendi G.A., Hernandez J.Z., Batalle J.P., et al. Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease. Nat Med 15 1 (2009) 34-41
10. Goetsch L., Plotnicky-Gilquin H., Aubry J.P., De-Lys P., Haeuw J.F., Bonnefoy J.Y., et al. BBG2Na an RSV subunit vaccine candidate intramuscularly injected to human confers protection against viral challenge after nasal immunization in mice. Vaccine 19 28-29 (2001) 4036-4042
11. van Drunen Littel-van den Hurk S., Mapletoft J.W., Arsic N., and Kovacs-Nolan J. Immunopathology of RSV infection: prospects for developing vaccines without this complication. Rev Med Virol 17 1 (2007) 5-34
12. Goulder P.J., Lechner F., Klenerman P., McIntosh K., and Walker B.D. Characterization of a novel respiratory syncytial virus-specific human cytotoxic T-lymphocyte epitope. J Virol 74 16 (2000) 7694-7697
13. Cherrie A.H., Anderson K., Wertz G.W., and Openshaw P.J. Human cytotoxic T cells stimulated by antigen on dendritic cells recognize the N, SH, F, M, 22K, and 1b proteins of respiratory syncytial virus. J Virol 66 4 (1992) 2102-2110
14. Venter M., Rock M., Puren A.J., Tiemessen C.T., and Crowe Jr. J.E. Respiratory syncytial virus nucleoprotein-specific cytotoxic T-cell epitopes in a South African population of diverse HLA types are conserved in circulating field strains. J Virol 77 13 (2003) 7319-7329
15. King A.M., Stott E.J., Langer S.J., Young K.K., Ball L.A., and Wertz G.W. Recombinant vaccinia viruses carrying the N gene of human respiratory syncytial virus: studies of gene expression in cell culture and immune response in mice. J Virol 61 9 (1987) 2885-2890
16. Connors M., Collins P.L., Firestone C.Y., and Murphy B.R. Respiratory syncytial virus (RSV) F, G, M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived. J Virol 65 3 (1991) 1634-1637
17. Taylor G., Thomas L.H., Furze J.M., Cook R.S., Wyld S.G., Lerch R., et al. Recombinant vaccinia viruses expressing the F, G or N, but not the M2, protein of bovine respiratory syncytial virus (BRSV) induce resistance to BRSV challenge in the calf and protect against the development of pneumonic lesions. J Gen Virol 78 Pt 12 (1997) 3195-3206
18. Boxus M., Tignon M., Roels S., Toussaint J.F., Walravens K., Benoit M.A., et al. DNA immunization with plasmids encoding fusion and nucleocapsid proteins of bovine respiratory syncytial virus induces a strong cell-mediated immunity and protects calves against challenge. J Virol 81 13 (2007) 6879-6889
19. Letellier C., Boxus M., Rosar L., Toussaint J.F., Walravens K., Roels S., et al. Vaccination of calves using the BRSV nucleocapsid protein in a DNA prime-protein boost strategy stimulates cell-mediated immunity and protects the lungs against BRSV replication and pathology. Vaccine 26 37 (2008) 4840-4848
20. Tran T.L., Castagne N., Bhella D., Varela P.F., Bernard J., Chilmonczyk S., et al. The nine C-terminal amino acids of the respiratory syncytial virus protein P are necessary and sufficient for binding to ribonucleoprotein complexes in which six ribonucleotides are contacted per N protein protomer. J Gen Virol 88 Pt 1 (2007) 196-206
21. Tawar R.G., Duquerroy S., Vonrhein C., Varela P.F., Damier-Piolle L., Castagne N., et al. Crystal structure of a nucleocapsid-like nucleoprotein-RNA complex of respiratory syncytial virus. Science 326 5957 (2009) 1279-1283
22. Roux X., Dubuquoy C., Durand G., Tran-Tolla T.L., Castagne N., Bernard J., et al. Sub-nucleocapsid nanoparticles: a nasal vaccine against respiratory syncytial virus. PLoS One 3 3 (2008) e1766
23. Valarcher J.F., Bourhy H., Gelfi J., and Schelcher F. Evaluation of a nested reverse transcription-PCR assay based on the nucleoprotein gene for diagnosis of spontaneous and experimental bovine respiratory syncytial virus infections. J Clin Microbiol 37 6 (1999) 1858-1862
24. Valarcher J.F., Bourhy H., Lavenu A., Bourges-Abella N., Roth M., Andreoletti O., et al. Persistent infection of B lymphocytes by bovine respiratory syncytial virus. Virology 291 1 (2001) 55-67
25. Hamel A.L., Wasylyshen M.D., and Nayar G.P. Rapid detection of bovine viral diarrhea virus by using RNA extracted directly from assorted specimens and a one-tube reverse transcription PCR assay. J Clin Microbiol 33 2 (1995) 287-291
26. Espinasse J., Peel J.E., Voirol M.J., Schelcher F., and Valarcher J.F. Absence of circulating TNF alpha in experimental bovine pneumonic pasteurellosis. Vet Rec 132 12 (1993) 303-304
27. Boxus M., Letellier C., and Kerkhofs P. Real time RT-PCR for the detection and quantitation of bovine respiratory syncytial virus. J Virol Methods 125 2 (2005) 125-130
28. Leutenegger C.M., Alluwaimi A.M., Smith W.L., Perani L., and Cullor J.S. Quantitation of bovine cytokine mRNA in milk cells of healthy cattle by real-time TaqMan polymerase chain reaction. Vet Immunol Immunopathol 77 3-4 (2000) 275-287
29. Gaddum R.M., Cook R.S., Furze J.M., Ellis S.A., and Taylor G. Recognition of bovine respiratory syncytial virus proteins by bovine CD8+ T lymphocytes. Immunology 108 2 (2003) 220-229
30. Belknap E.B., Baker J.C., Patterson J.S., Walker R.D., Haines D.M., and Clark E.G. The role of passive immunity in bovine respiratory syncytial virus-infected calves. J Infect Dis 163 3 (1991) 470-476
31. Salt J.S., Thevasagayam S.J., Wiseman A., and Peters A.R. Efficacy of a quadrivalent vaccine against respiratory diseases caused by BHV-1, PI3V, BVDV and BRSV in experimentally infected calves. Vet J 174 3 (2007) 616-626
32. Vangeel I., Antonis A.F., Fluess M., Riegler L., Peters A.R., and Harmeyer S.S. Efficacy of a modified live intranasal bovine respiratory syncytial virus vaccine in 3-week-old calves experimentally challenged with BRSV. Vet J 174 3 (2007) 627-635
33. Bryson D.G., Adair B.M., McNulty M.S., McAliskey M., Bradford H.E., Allan G.M., et al. Studies on the efficacy of intranasal vaccination for the prevention of experimentally induced parainfluenza type 3 virus pneumonia in calves. Vet Rec 145 2 (1999) 33-39
34. Adair B.M., Bradford H.E., McNulty M.S., and Foster J.C. Cytotoxic interactions between bovine parainfluenza type 3 virus and bovine alveolar macrophages. Vet Immunol Immunopathol 67 3 (1999) 285-294
35. West K., Petrie L., Konoby C., Haines D.M., Cortese V., and Ellis J.A. The efficacy of modified-live bovine respiratory syncytial virus vaccines in experimentally infected calves. Vaccine 18 9-10 (1999) 907-919
36. Woolums A.R., Anderson M.L., Gunther R.A., Schelegle E.S., LaRochelle D.R., Singer R.S., et al. Evaluation of severe disease induced by aerosol inoculation of calves with bovine respiratory syncytial virus. Am J Vet Res 60 4 (1999) 473-480
37. Frankild S., de Boer R.J., Lund O., Nielsen M., and Kesmir C. Amino acid similarity accounts for T cell cross-reactivity and for "holes" in the T cell repertoire. PLoS One 3 3 (2008) e1831
38. Piazza F.M., Johnson S.A., Darnell M.E., Porter D.D., Hemming V.G., and Prince G.A. Bovine respiratory syncytial virus protects cotton rats against human respiratory syncytial virus infection. J Virol 67 3 (1993) 1503-1510
39. Taylor G., Bruce C., Barbet A.F., Wyld S.G., and Thomas L.H. DNA vaccination against respiratory syncytial virus in young calves. Vaccine 23 10 (2005) 1242-1250
40. Kimman T.G., Westenbrink F., and Straver P.J. Priming for local and systemic antibody memory responses to bovine respiratory syncytial virus: effect of amount of virus, virus replication, route of administration and maternal antibodies. Vet Immunol Immunopathol 22 2 (1989) 145-160
41. Woolums A.R., Brown C.C., Brown Jr. J.C., Cole D.J., Scott M.A., Williams S.M., et al. Effects of a single intranasal dose of modified-live bovine respiratory syncytial virus vaccine on resistance to subsequent viral challenge in calves. Am J Vet Res 65 3 (2004) 363-372
42. Ellis J., Gow S., West K., Waldner C., Rhodes C., Mutwiri G., et al. Response of calves to challenge exposure with virulent bovine respiratory syncytial virus following intranasal administration of vaccines formulated for parenteral administration. J Am Vet Med Assoc 230 2 (2007) 233-243
43. Bembridge G.P., MacHugh N.D., McKeever D., Awino E., Sopp P., Collins R.A., et al. CD45RO expression on bovine T cells: relation to biological function. Immunology 86 4 (1995) 537-544
44. Hogg A.E., Worth A., Beverley P., Howard C.J., and Villarreal-Ramos B. The antigen-specific memory CD8+ T-cell response induced by BCG in cattle resides in the CD8+ gamma/deltaTCR-CD45RO+ T-cell population. Vaccine 27 2 (2009) 270-279
45. McInnes E., Sopp P., Howard C.J., and Taylor G. Phenotypic analysis of local cellular responses in calves infected with bovine respiratory syncytial virus. Immunology 96 3 (1999) 396-403
46. Antonis A.F., Claassen E.A., Hensen E.J., de Groot R.J., de Groot-Mijnes J.D., Schrijver R.S., et al. Kinetics of antiviral CD8 T cell responses during primary and post-vaccination secondary bovine respiratory syncytial virus infection. Vaccine 24 10 (2006) 1551-1561
47. Taylor G., Thomas L.H., Wyld S.G., Furze J., Sopp P., and Howard C.J. Role of T-lymphocyte subsets in recovery from respiratory syncytial virus infection in calves. J Virol 69 11 (1995) 6658-6664
48. Gaddum R.M., Cook R.S., Thomas L.H., and Taylor G. Primary cytotoxic T-cell responses to bovine respiratory syncytial virus in calves. Immunology 88 3 (1996) 421-427